Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Clinical Pig Kidney Xenotransplantation: How Close Are We?

Cooper DKC, Hara H, Iwase H, Yamamoto T, Jagdale A, Kumar V, Mannon RB, Hanaway MJ, Anderson DJ, Eckhoff DE.

J Am Soc Nephrol. 2020 Jan;31(1):12-21. doi: 10.1681/ASN.2019070651. Epub 2019 Dec 2.

PMID:
31792154
2.

Donation approval among obese living kidney donor candidates: The impact of metabolic syndrome.

Mustian MN, Kumar V, Hanaway M, MacLennan PA, Shelton BA, Reed RD, Correya T, Grant R, Carter A, Baker G, Patterson J, Peoples M, Holden S, Orandi BJ, Locke JE.

Surgery. 2019 Nov;166(5):940-946. doi: 10.1016/j.surg.2019.07.008. Epub 2019 Aug 20.

PMID:
31444005
3.

Mitigating Racial and Sex Disparities in Access to Living Donor Kidney Transplantation: Impact of the Nation's Longest Single-center Kidney Chain.

Mustian MN, Kumar V, Stegner K, Mompoint-Williams D, Hanaway M, Deierhoi MH, Young C, Orandi BJ, Anderson D, MacLennan PA, Reed RD, Shelton BA, Eckhoff D, Locke JE.

Ann Surg. 2019 Oct;270(4):639-646. doi: 10.1097/SLA.0000000000003484.

PMID:
31348035
4.

Patient Perspectives on Weight Management for Living Kidney Donation.

Mustian MN, Hanaway M, Kumar V, Reed RD, Shelton BA, Grant R, Carter A, Locke JE.

J Surg Res. 2019 Dec;244:50-56. doi: 10.1016/j.jss.2019.06.026. Epub 2019 Jul 3.

PMID:
31279263
5.

Enhanced Advocacy and Health Systems Training Through Patient Navigation Increases Access to Living-donor Kidney Transplantation.

Locke JE, Reed RD, Kumar V, Berry B, Hendricks D, Carter A, Shelton BA, Mustian MN, MacLennan PA, Qu H, Hannon L, Yates C, Hanaway MJ.

Transplantation. 2020 Jan;104(1):122-129. doi: 10.1097/TP.0000000000002732.

PMID:
30946213
6.

Population Health, Ethnicity, and Rate of Living Donor Kidney Transplantation.

Reed RD, Sawinski D, Shelton BA, MacLennan PA, Hanaway M, Kumar V, Long D, Gaston RS, Kilgore ML, Julian BA, Lewis CE, Locke JE.

Transplantation. 2018 Dec;102(12):2080-2087. doi: 10.1097/TP.0000000000002286.

7.

Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes: A 15-year Single-center Experience.

Young CJ, MacLennan PA, Mannon EC, Reed RD, Shelton BA, Hanaway MJ, Agarwal G, Gaston RS, Julian BA, Kew CE 2nd, Kumar V, Mannon RB, Mehta S, Ong SC, Towns GC, Deierhoi MH, Locke JE.

Ann Surg. 2020 Jan;271(1):177-183. doi: 10.1097/SLA.0000000000002816.

PMID:
29781845
8.

Preoperative arterial microcalcification and clinical outcomes of arteriovenous fistulas for hemodialysis.

Allon M, Robbin ML, Umphrey HR, Young CJ, Deierhoi MH, Goodman J, Hanaway M, Lockhart ME, Barker-Finkel J, Litovsky S.

Am J Kidney Dis. 2015 Jul;66(1):84-90. doi: 10.1053/j.ajkd.2014.12.015. Epub 2015 Feb 18.

9.

Preoperative venous intimal hyperplasia, postoperative arteriovenous fistula stenosis, and clinical fistula outcomes.

Allon M, Robbin ML, Young CJ, Deierhoi MH, Goodman J, Hanaway M, Lockhart ME, Litovsky S.

Clin J Am Soc Nephrol. 2013 Oct;8(10):1750-5. doi: 10.2215/CJN.02740313. Epub 2013 Jun 27.

10.

Correlation of pre-existing vascular pathology with arteriovenous graft outcomes in hemodialysis patients.

Allon M, Litovsky S, Young CJ, Deierhoi MH, Goodman J, Hanaway M, Lockhart ME, Robbin ML.

Am J Kidney Dis. 2013 Dec;62(6):1122-9. doi: 10.1053/j.ajkd.2013.03.040. Epub 2013 Jun 5.

11.

Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturation.

Allon M, Litovsky S, Young CJ, Deierhoi MH, Goodman J, Hanaway M, Lockhart ME, Robbin ML.

Am J Kidney Dis. 2011 Sep;58(3):437-43. doi: 10.1053/j.ajkd.2011.04.018. Epub 2011 Jun 30.

12.

Alemtuzumab induction in renal transplantation.

Hanaway MJ, Woodle ES, Mulgaonkar S, Peddi VR, Kaufman DB, First MR, Croy R, Holman J; INTAC Study Group.

N Engl J Med. 2011 May 19;364(20):1909-19. doi: 10.1056/NEJMoa1009546.

13.

Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients.

Martin JE, Cavanaugh TM, Trumbull L, Bass M, Weber F Jr, Aranda-Michel J, Hanaway M, Rudich S.

Clin Transplant. 2008 Jan-Feb;22(1):113-9. doi: 10.1111/j.1399-0012.2007.00780.x.

PMID:
18217912
14.

New trends in immunosuppression in transplant patients.

Hanaway MJ, Sollinger HW.

Saudi J Kidney Dis Transpl. 2000 Apr-Jun;11(2):137-44. No abstract available.

15.

Temporary silastic mesh closure for adult liver transplantation: a safe alternative for the difficult abdomen.

Jafri MA, Tevar AD, Lucia M, Thambi-Pillai T, Karachristos A, Trumbull L, Buell JF, Thomas MJ, Hanaway MJ, Woodle ES, Rudich SM.

Liver Transpl. 2007 Feb;13(2):258-65.

16.

Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantation.

Alexander JW, Goodman HR, Cardi M, Austin J, Goel S, Safdar S, Huang S, Munda R, Fidler JP, Buell JF, Hanaway M, Susskind B, Roy-Chaudhury P, Trofe J, Alloway R, Woodle ES.

Transpl Int. 2006 Apr;19(4):295-302.

17.

Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: a matched control study.

Gearhart M, Martin J, Rudich S, Thomas M, Wetzel D, Solomkin J, Hanaway MJ, Aranda-Michel J, Weber F, Trumball L, Bass M, Zavala E, Steve Woodle E, Buell JF.

Clin Transplant. 2005 Dec;19(6):711-6.

PMID:
16313314
18.

Pilot study of early corticosteroid elimination after pancreas transplantation.

Hanaway MJ, Roy-Chaudhury P, Buell JF, Thomas M, Munda R, Alloway RR, Ellison V, Rudich SM, Fisher L, Woodle ES.

Transplant Proc. 2005 Mar;37(2):1287-8.

PMID:
15848698
19.

Methicillin-resistant Staphylococcus aureus infection in liver transplantation: a matched controlled study.

Schneider CR, Buell JF, Gearhart M, Thomas M, Hanaway MJ, Rudich SM, Woodle ES.

Transplant Proc. 2005 Mar;37(2):1243-4.

PMID:
15848683
20.

Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience.

Buell JF, Hanaway MJ, Thomas M, Alloway RR, Woodle ES.

Transplant Proc. 2005 Mar;37(2):962-3.

PMID:
15848591
21.

De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population.

Buell JF, Papaconstantinou HT, Skalow B, Hanaway MJ, Alloway RR, Woodle ES.

Transplant Proc. 2005 Mar;37(2):960-1.

PMID:
15848590
22.

Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience.

Woodle ES, Gupta M, Buell JF, Neff GW, Gross TG, First MR, Hanaway MJ, Trofe J.

Transplant Proc. 2005 Mar;37(2):958-9.

PMID:
15848589
23.

Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience.

Buell JF, Gross TG, Hanaway MJ, Trofe J, Muthiak C, First MR, Alloway RR, Woodle ES.

Transplant Proc. 2005 Mar;37(2):956-7.

PMID:
15848588
24.

Posttransplant lymphoproliferative disorder: significance of central nervous system involvement.

Buell JF, Gross TG, Hanaway MJ, Trofe J, Roy-Chaudhury P, First MR, Woodle ES.

Transplant Proc. 2005 Mar;37(2):954-5.

PMID:
15848587
25.

Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis.

Boardman R, Trofe J, Alloway R, Rogers C, Roy-Chaudhury P, Cardi M, Safdar S, Groene B, Buell J, Hanaway M, Thomas M, Alexander W, Munda R, Woodle ES.

Transplant Proc. 2005 Mar;37(2):817-8.

PMID:
15848542
26.

African American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression.

Boardman RE, Alloway RR, Alexander JW, Buell JF, Cardi M, First MR, Hanaway MT, Munda R, Rogers CC, Roy-Chaudhury P, Susskind B, Trofe J, Woodle ES.

Transplant Proc. 2005 Mar;37(2):814-6.

PMID:
15848541
27.

Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation.

Rogers CC, Alloway RR, Boardman R, Trofe J, Hanaway MJ, Alexander JW, Roy-Chaudhury P, Buell JF, Thomas M, Susskind B, Woodle ES.

Transplant Proc. 2005 Mar;37(2):812-3.

PMID:
15848540
28.

Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimens.

Woodle ES, Susskind B, Alloway RR, Hanaway MJ, Thomas M, Buell J, Alexander JW, Roy-Chaudhury P, Succop P, Cardi M, Boardman R, Rogers C.

Transplant Proc. 2005 Mar;37(2):809-11.

PMID:
15848539
29.

A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience.

Alloway RR, Hanaway MJ, Trofe J, Boardman R, Rogers CC, Hanaway MJ, Buell JF, Munda R, Alexander JW, Thomas MJ, Roy-Chaudhury P, Cardi M, Woodle ES.

Transplant Proc. 2005 Mar;37(2):802-3.

PMID:
15848537
30.

Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression.

Rogers CC, Alloway RR, Hanaway M, Buell JF, Roy-Chaudhury P, Succop P, Woodle ES.

Transplant Proc. 2005 Mar;37(2):800-1.

PMID:
15848536
31.

Early corticosteroid withdrawal under modern immunosuppression in renal transplantation: multivariate analysis of risk factors for acute rejection.

Woodle ES, Alloway RR, Hanaway MJ, Buell JF, Thomas M, Roy-Chaudhury P, Trofe J.

Transplant Proc. 2005 Mar;37(2):798-9.

PMID:
15848535
32.

Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy.

Rogers CC, Hanaway M, Alloway RR, Alexander JW, Boardman RE, Trofe J, Gupta M, Merchen T, Buell JF, Cardi M, Roy-Chaudhury P, Succop P, Woodle ES.

Transplant Proc. 2005 Mar;37(2):795-7.

PMID:
15848534
33.

Laparoscopic right living donor nephrectomy.

Husted TL, Hanaway MJ, Thomas MJ, Woodle ES, Buell JF.

Transplant Proc. 2005 Mar;37(2):631-2.

PMID:
15848481
34.

Laparoscopic living donor nephrectomy for kidneys with multiple arteries.

Husted TL, Hanaway MJ, Thomas MJ, Woodle ES, Buell JF.

Transplant Proc. 2005 Mar;37(2):629-30.

PMID:
15848480
35.

Donor kidneys with small renal cell cancers: can they be transplanted?

Buell JF, Hanaway MJ, Thomas M, Munda R, Alloway RR, First MR, Woodle ES.

Transplant Proc. 2005 Mar;37(2):581-2.

PMID:
15848463
36.

Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience.

Trofe J, Buell JF, Beebe TM, Hanaway MJ, First MR, Alloway RR, Gross TG, Succop P, Woodle ES.

Am J Transplant. 2005 Apr;5(4 Pt 1):775-80.

37.

United network for organ sharing publication on scientific registry of transplant recipients central nervous system donor cancer transmission data.

Buell JF, Beebe TM, Gross TG, Trofe J, Hanaway MJ, Alloway RR, First MR, Woodle ES.

Transplantation. 2005 Mar 15;79(5):623. No abstract available.

PMID:
15753859
38.

Laparoscopic donor nephrectomy vs. open live donor nephrectomy: a quality of life and functional study.

Buell JF, Lee L, Martin JE, Dake NA, Cavanaugh TM, Hanaway MJ, Weiskittel P, Munda R, Alexander JW, Cardi M, Peddi VR, Zavala EY, Berilla E, Clippard M, First MR, Woodle ES.

Clin Transplant. 2005 Feb;19(1):102-9.

PMID:
15659142
39.

African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression.

Boardman RE, Alloway RR, Alexander JW, Buell JF, Cardi M, First MR, Hanaway MJ, Munda R, Rogers CC, Roy-Chaudhury P, Susskind B, Trofe J, Woodle ES.

Am J Transplant. 2005 Feb;5(2):356-65.

40.

Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer.

Papaconstantinou HT, Sklow B, Hanaway MJ, Gross TG, Beebe TM, Trofe J, Alloway RR, Woodle ES, Buell JF.

Dis Colon Rectum. 2004 Nov;47(11):1898-903.

PMID:
15622583
41.

Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry.

Aull MJ, Buell JF, Trofe J, First MR, Alloway RR, Hanaway MJ, Wagoner L, Gross TG, Beebe T, Woodle ES.

Transplantation. 2004 Dec 15;78(11):1676-82.

PMID:
15591959
42.

Posttransplant malignancy.

Trofe J, Beebe TM, Buell JF, Hanaway MJ, First MR, Alloway RR, Gross TG, Woodle ES.

Prog Transplant. 2004 Sep;14(3):193-200. Review.

PMID:
15495778
43.

Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma.

Trofe J, Buell JF, Woodle ES, Beebe TM, Hanaway MJ, First MR, Alloway RR, Gross TG.

Transplantation. 2004 Oct 15;78(7):972-7.

PMID:
15480161
44.

Donor transmitted malignancies.

Buell JF, Beebe TM, Trofe J, Gross TG, Alloway RR, Hanaway MJ, Woodle ES.

Ann Transplant. 2004;9(1):53-6. Review.

45.

Right donor nephrectomy: a comparison of hand-assisted transperitoneal and retroperitoneal laparoscopic approaches.

Buell JF, Abreu SC, Hanaway MJ, Ng CS, Kaouk JH, Clippard M, Zaki S, Goldfarb DA, Woodle ES, Gill IS.

Transplantation. 2004 Feb 27;77(4):521-5.

PMID:
15084928
46.

West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death.

DeSalvo D, Roy-Chaudhury P, Peddi R, Merchen T, Konijetti K, Gupta M, Boardman R, Rogers C, Buell J, Hanaway M, Broderick J, Smith R, Woodle ES.

Transplantation. 2004 Feb 15;77(3):466-9.

PMID:
14966429
47.

The Israel Penn International Transplant Tumor Registry.

Witherow BA, Roth GS, Carrozza MA, Freyberg RW, Kopke JE, Alloway RR, Buell JF, First MR, Gross TG, Hanaway MJ, Trofe J, Woodle ES, Beebe TM.

AMIA Annu Symp Proc. 2003:1053.

48.

Donors with central nervous system malignancies: are they truly safe?

Buell JF, Trofe J, Sethuraman G, Hanaway MJ, Beebe TM, Gross TG, Alloway R, First MR, Woodle ES.

Transplantation. 2003 Jul 27;76(2):340-3.

PMID:
12883189
49.

MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literature.

Aull MJ, Buell JF, Peddi VR, Trofe J, Beebe TM, Hanaway MJ, Roy-Chaudhury P, Alloway RR, First MR, Woodle ES; Israel Penn International Transplant Tumor Registry.

Transplantation. 2003 Jan 27;75(2):225-8.

PMID:
12548128
50.

Supplemental Content

Loading ...
Support Center